Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20150032Phase 3Completed
A Phase 3 trial of botulinum toxin type A in glabellar furrowing, sponsored by Ipsen. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20150032.